Table 3.

Pairwise comparisons of TSH target range achievement between treatment and nontreatment cohorts at each follow-up time point

	OR	95% CI	P value
Treatment vs. nontreatment at 6 months	2.38	1.3960, 4.0720	0.0015
Treatment vs. nontreatment at 12 months	1.08	0.6880, 1.7000	0.7324
Treatment vs. nontreatment at 18 months	2.11	1.3310, 3.3540	0.0016
Treatment vs. nontreatment at 24 months	2.63	1.6460, 4.1870	0.0001

GLMM with repeated measures used to assess whether proportion of patients were different in treatment vs. nontreatment cohorts. TSH target: 0.45–4.12 mIU/L

CI confidence interval, GLMM generalized linear mixed model, OR odds ratio, TSH thyroid-stimulating hormone